Research and Markets: 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

Business Wire

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/gz9g3s/10th_annual) has announced the addition of the "10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report to their offering.

The 2013 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production. This year's 10th Annual Report and Survey of Biopharmaceutical Manufacturing shows the industry has returned to robust growth.

Based on analysis of 238 global biomanufacturers' 2013 budgets, expect substantial investment in new technologies that:

- Reduce costs and improve productivity

- Focus on novel downstream technologies

- Improve single-use device adoption rates

This year, among the hundreds of significant findings: Budgets are growing in all areas measured, but the great majority are continuing to actively implement cost-cutting initiatives; a broad range of new products are being demanded from industry vendors to solve productivity problems, especially in single use and chromatography areas.

This report's 534 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more:

- Biosimilars pipeline in development

- In-depth analysis of key data, capacity, production trends, and benchmarks

- Budget trends and impact of current economic environment

- Expression system advances

- Downstream purification problems and issues

- Current and projected industry bottlenecks

- Capacity utilization and current production levels

- How capacity bottlenecks are being resolved

- Production trends and implications for industry

- Outsourcing trends

- International offshoring through 2017

- Range of titres, growth

- Disposables: Spending growth; downstream uses; L&E's; reasons for increasing/ restricting; budget increases; vendor satisfaction

- Disposables: Compare innovators vs CMOs & US vs Europe

- Batch failure rates & trends

- Selecting a CMO - Problems & solutions

- Quality management & PAT implementation

- Hiring and employment growth

- Supplier growth rates

- Much more...

Compare 238 biotherapeutic developers vs CMOs; US vs European & Global Biomanufacturing

Key Topics Covered

Overview

Methodology

1: Introduction and Discussion

2: Demographics

3: Emerging Issues in Biopharmaceutical Manufacturing

4: Capacity Utilization

5: Current Capacity Constraints

6: Future Capacity Expansions

7: Outsourcing Trends in Biopharmaceutical Manufacturing

8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing

9: Downstream Purification

10: Quality Issues, Batch Failures, and PAT in Biopharmaceutical Manufacturing

11: Hiring, Employment Growth and Training in Biopharmaceutical Manufacturing

12: Suppliers to Biopharmaceutical Manufacturing and Life Sciences

For more information visit http://www.researchandmarkets.com/research/gz9g3s/10th_annual

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contact:
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Pharmaceuticals
View Comments